2.Preliminary analysis on the treatment of infection caused by pandrug-resistant Acinetobacter baumannii
Yan SHI ; Da-Wei LIU ; Da-Bo XU ; Ying-Chun XU ; Min-Jun CHEN ; Hui WANG ;
Chinese Journal of Infection and Chemotherapy 2007;0(01):-
Objective To analyze the clinical features of pandrug-resistant Acinetobacter baumannii (PDR-Ab) in a hospital and compare the efficacy of different antibiotic treatments on patients with pneumonia caused by PDR-Ab.Methods Data were ret- rospectively collected from all isolated PDR-Ab strains in our hospital from February 2004 to March 2005.The clinical features and outcomes were reviewed.Results A total of 77 strains of PDR-Ab were collected, 45 of which were pathogens causing clini- cal infections (35 strains from lower respiratory tract, 6 from bloodstream, 3 from drainage fluid, and 1 from wounds).Lower respiratory tract was the most common source of PDR-Ab.More than 90% of the isolated PDR-Ab strains produced OXA-23 type?-lactamase.Cefoperazone-sulbactam plus minocyeline showed good efficacy for patients with PDR-Ab pneumonia.The total clinical cure rate was 68.4%.Bacterial eradication rate was 42.1%.The factors influencing bacterial clearance were pro- longed mechanical ventilation prior to positive culture (17.5 d vs 5.5 d).mixed infection (100% vs 12.5%) and lower GCS score (9.1?0.7 vs 13.2?2.1).Concomitant septic shock (OR=13.8) and APACHEⅡscore (OR=2.1) were independent factors of clinical outcome.Conclusions Nosocomial infections caused by PDR-Ab are not untreatable.Our analysis suggests that cefoperazone-sulbactam plus minocycline may be an effective treatment for lower respiratory tract infections caused by PDR-Ab in our hospital.
3.Development of premium healthcare industry:International experience and implications
Xinye FANG ; Lili SHI ; Xianji WANG ; Linan WANG ; Chen FU ; Chunlin JIN ; Da HE
Chinese Journal of Health Policy 2015;8(3):5-9
Premium healthcare is the key area of healthcare industry and private medical institutions. Howev-er, with the expansion of VIP services in public hospitals and policy barriers to private medical institutions, the de-velopment of premium healthcare in China is still in its early stage. The premium healthcare industry has in fact be-gun to take shape in some developed countries, accumulating rich experience in the aspects of developing bases, op-erating modes and security systems. Therefore, this paper introduces the experiences of premium healthcare develop-ment in several countries:the United Kingdom, the United States, Germany, Singapore, Australia, and India: the building of safety net hospitals;the setting of hierarchical pricing and differential financial assistance;the use of pub-lic-private partnership based on commercial health insurance to determine prioritization. Based on the actual situation in China, this paper provides some implications to develop premium healthcare, including the implementation of dif-ferential payment policies built on the provision of basic healthcare services, the promotion of commercial health in-surance and public-private partnerships, and the determination of preferential areas.
4.Concept, connotation and priorities of premium healthcare:A case study of Shanghai
Chunlin JIN ; Da HE ; Chen FU ; Linan WANG ; Xinye FANG ; Lili SHI ; Xianji WANG
Chinese Journal of Health Policy 2015;8(3):1-4
Premium healthcare is one of the major components of private healthcare, a key part of the health service industry, and one of the significant areas of the Thirteenth Five-Year Plan of health. However, there is no clear definition of premium healthcare that is widely accepted based on a Chinese literature review, and to define the concept of premium healthcare is the basis and premise for research. This paper adopted the methods of systematic re-view, field investigation and key person interviews to clarify the definition of premium healthcare and the results sug-gested that areas of health management, medical care for the elderly, mobile medical care, and so on should be the priorities of premium healthcare development.
5.Criteria for assessing clinical therapeutic effect of chronic urticaria in China
Chunrui SHI ; Kangbing CHEN ; Min WANG ; Xiaojing DA ; Jiyuan DONG ; Qianhua KUANG ; Wanming REN
Chinese Journal of Medical Library and Information Science 2014;(12):43-47
Objective To investigate the criteria for assessing the clinical therapeutic effect of chronic urticaria in China.Methods The application of criteria for assessing the clinical therapeutic effect of chronic urticaria in China and their applicable scope were analyzed by frequency analysis and K-means clustering analysis, respectively.Results The criteria for assessing symptoms and therapeutic effect were different in the 857 papers included in this study. SSRI was used in 549 (64.17) out of the 857 papers included in this study.K-means clustering analysis showed that the applicable scope of SSRI with curative rate ( 100%≥SSRI>90%) , improvement rate ( 90%≥SSR<60%) , Significant effect rate (60%≥SSRI>20%) , and no response rate (20%≥SSR≥0%) as its criteria was wider than that of frequency analysis.Conclusion The criteria for the clinical assessment of chronic urticaria and its drug treatment effect should be unified and standardized.
6.Culture of pancreatic duct-derived stem cells of rats in vitro in the dynamic three-dimension cell culture system
Xuchun CHEN ; Ying CHENG ; Guichen LI ; Rui SHI ; Xiaohang LI ; Da LI ; Yongfeng LIU
Chinese Journal of Organ Transplantation 2012;33(6):371-375
Objective To isolate,purify and identify pancreatic duct derived stem cells (PDSCs) from the pancreatic duct of rats,and culture in the three-dimension cell culture system.Methods Adult male Wistar rats underwent perfusion with collagenase V via the pancreatic duct,then the pancreas was surgically procured,digested,followed by discontinued density gradient centrifuge to isolate ductal tissue from islets.The acinar and ductal tissue was cultivated in serumcontaining medium in the three-dimension cell culture to obtain adherent cells,as PDSCs,which were expanded by consecutive passages.The morphology and characterization of PDSCs on phenotype were examined.Results PDSCs could be obtained through in situ collagenase V digestion,discontinued density gradient centrifuge,and culture in the three dimension cell culture system.Morphologically,PDSCs had remarkable size,most with one nucleus.PDSCs grew in many layers in three-dimension cell culture system.PDSCs was revealed to express CD29,CD73,CD90,CD105,but not CD14,CD19,CD34,CD45 by FACS,in agreement with MSCs.Conclusion PDSCs of rats could be obtained through in situ collagenase V digestion,discontinued density gradient centrifuge,and culture in the three-dimension cell culture system.PDSCs lines were successfully established.
7.Beard reconstruction by single-hair grafting technique
Jincai GUO ; Sufan WU ; Hangyan SHI ; Zhiming ZHANG ; Sheng YAN ; Da CHEN ; Yi SUN
Chinese Journal of Medical Aesthetics and Cosmetology 2008;14(3):174-176
Objective To search for a good solution for aesthetic beard reconstruction and to explore the effect of the single-hair grafting in beard reconstruction. Methods Under the local anesthesia, a scalp strip (length range from 5~7 cm, width range from 1.0~1.5 cm) was harvested from the back of the head and then was divided into a series of single-hair micrografts. After the slits were made, the grafts were implanted into the holes, parallel to the original beard directions. The donor sites were directly closed. With this method, 18 sparse beard patients and 3 patients with upper lip scars were treated. Results The grafted hairs grew nearly in the direction of normal beard, which achieved 90 %~95 % survival in recipient areas. The patients were satisfied with the results, in which 19 cases received only 1 operation and 2 cases received another repeated operation. Conclusion Beard reconstruction by single-hair grafting technique is a good, safe and effective method.
8.The criterion of syndrome differentiation and quantification for stable coronary heart disease caused by etiological toxin of Chinese medicine.
Ke-ji CHEN ; Da-zhuo SHI ; Hao XU
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(3):313-314
Contemporary Chinese medicine supposes that the blood stasis is a pivotal pathogenic mechanism of coronary heart disease (CHD). The presentation and pathological changes in acute cardiovascular events of CHD, however, seem to exceed the etiological category of blood stasis. The toxin or the combination and transformation of toxin and blood stasis of Chinese medicine are involved in the pathogenesis of CHD according to the basic theory of Chinese medicine. Therefore, to establish a criterion of differentiation and diagnosis for stable CHD caused by etiological toxin of Chinese medicine applying clinical epidemiological method, which is correlated to concept of evidence based medicine, is significant in early recognizing high risk patients and improving treatment of CHD.
Coronary Disease
;
diagnosis
;
pathology
;
Humans
;
Integrative Medicine
;
Medicine, Chinese Traditional
9.Spindle cell variants of diffuse large B cell lymphoma: report of 2 cases.
Jun-chen WANG ; Da-ren SHI ; Xue-lian FU ; Chang-li LU ; Wan-ping LU
Chinese Journal of Pathology 2005;34(1):55-56
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Breast
;
pathology
;
Breast Neoplasms
;
drug therapy
;
pathology
;
Cyclophosphamide
;
therapeutic use
;
Diagnosis, Differential
;
Doxorubicin
;
therapeutic use
;
Female
;
Follow-Up Studies
;
Humans
;
Lymphoma, B-Cell
;
drug therapy
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
drug therapy
;
pathology
;
Male
;
Middle Aged
;
Prednisone
;
therapeutic use
;
Sarcoma
;
pathology
;
Spleen
;
pathology
;
Splenic Neoplasms
;
drug therapy
;
pathology
;
Vincristine
;
therapeutic use
10.Research of cardiovascular effects and mechanism of Panax quinquefolius saponin.
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(6):825-831
Panax quinquefolium L., also named American ginseng, is a valuable tonic medicine. Because of its main active ingredient ginsenoside's extensive biological effects, researches on the Panax quinquefolius saponin have important clinical and scientific value. Its basic components, bioactivities, cardiovascular effects and mechanisms will be covered in this paper.
Animals
;
Cardiovascular System
;
drug effects
;
Humans
;
Saponins
;
pharmacology